| |
| |
| |
Basic Topics | |
| |
| |
| |
Introduction | |
| |
| |
Pharmacoeconomics-What Is It? | |
| |
| |
Why Is Pharmacoeconomics Important? | |
| |
| |
Relationship of Pharmacoeconomics to Other Research | |
| |
| |
Types of Pharmacoeconomic Studies | |
| |
| |
Summary | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Measuring and Estimating Costs | |
| |
| |
Costing Terms | |
| |
| |
Cost Categorization | |
| |
| |
Alternative Method of Categorization | |
| |
| |
Perspective | |
| |
| |
Timing Adjustments for Costs | |
| |
| |
Resources for Cost Estimations | |
| |
| |
Summary | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Critiquing Research Articles | |
| |
| |
Appropriateness of Methods of Analysis | |
| |
| |
Questions to Use When Critiquing Research Articles | |
| |
| |
Summary | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Cost-Minimization Analysis | |
| |
| |
Overview | |
| |
| |
Summary | |
| |
| |
Composite Article: CMA-Anti-nausea | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Cost-Effectiveness Analysis | |
| |
| |
Overview | |
| |
| |
Presentation of Costs and Effectiveness | |
| |
| |
Cost-Effectiveness Grid II11T | |
| |
| |
Cost-Effectiveness Plane | |
| |
| |
Intermediate Outcomes versus Primary Outcomes | |
| |
| |
Efficacy versus Effectiveness | |
| |
| |
Consensus and Debate | |
| |
| |
Summary | |
| |
| |
Composite Article 1: CEA-Asthma | |
| |
| |
Composite Article 2: CEA-Post-Myocardial Infarction Heart Failure | |
| |
| |
Questions/Exercise | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Cost-Utility Analysis | |
| |
| |
Overview | |
| |
| |
Steps in Calculating QALYs | |
| |
| |
Trends in CUA Analyses | |
| |
| |
Summary | |
| |
| |
Composite Article 1: CUA-Oncology | |
| |
| |
Composite Article 2: CUA-Immunosuppression | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Cost-Benefit Analysis | |
| |
| |
Definition and History | |
| |
| |
Advantages and Disadvantages of Cost-Benefit Analysis | |
| |
| |
Conducting a CBA | |
| |
| |
Difference between Costs and Benefits | |
| |
| |
Measuring Indirect and Intangible Benefits | |
| |
| |
Calculating Results of Costs and Benefits | |
| |
| |
Summary | |
| |
| |
Composite Article 1: CBA-Vaccination | |
| |
| |
Composite Article 2: CBA-Alzheimer's Disease | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Health-Related Quality of Life: Health Status Measures | |
| |
| |
Definitions | |
| |
| |
HRQoL Measures versus Utility Measures | |
| |
| |
Domains of Health Status | |
| |
| |
Assessing HRQoL Instruments | |
| |
| |
Pharmacoeconomics and HRQoL Measures | |
| |
| |
Preference-Based Classification Systems | |
| |
| |
Patient-Reported Outcomes | |
| |
| |
Summary | |
| |
| |
Composite Article 1: HRQoL- Rheumatoid Arthritis | |
| |
| |
Composite Article 2: HRQoL-Chronic Low Back Pain | |
| |
| |
Questions/Exercises | |
| |
| |
References 16S | |
| |
| |
Suggested Readings | |
| |
| |
| |
Advanced Topics | |
| |
| |
| |
Decision Analysis | |
| |
| |
What Is Decision Analysis? | |
| |
| |
Steps in Decision Analysis | |
| |
| |
Threshold Analysis | |
| |
| |
Summary | |
| |
| |
Composite Article 1: Decision Analysis-Migraine | |
| |
| |
Composite Article 2: Decision Analysis-Erectile Dysfunction | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Markov Modeling | |
| |
| |
Overview | |
| |
| |
Steps in Markov Modeling | |
| |
| |
Disadvantages of Markov Modeling | |
| |
| |
Advanced Issues | |
| |
| |
Other Advanced Topics | |
| |
| |
Summary | |
| |
| |
Composite Article 1: Markov Modeling-Initiation of HIV Therapy | |
| |
| |
Answers | |
| |
| |
Composite Article 2: Markov Modeling-Phosphate Binders | |
| |
| |
Answers | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Retrospective Databases | |
| |
| |
Overview of Retrospective Databases | |
| |
| |
Randomized, Controlled Trials | |
| |
| |
Observational Studies | |
| |
| |
Advantages and Disadvantages of RCTs | |
| |
| |
Advantages and Disadvantages of Observational Studies | |
| |
| |
Types of Retrospective Databases | |
| |
| |
Insurance and Claims Records | |
| |
| |
Critiquing Retrospective Database Studies | |
| |
| |
Summary | |
| |
| |
Composite Article 1: Retrospective Database-COPD | |
| |
| |
Composite Article 2: Retrospective Database-Bisphosphonates | |
| |
| |
Questions/Exercise | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Pharmacy Services | |
| |
| |
What Are Pharmacy Services? | |
| |
| |
History of Pharmacy Services | |
| |
| |
Review of the Research | |
| |
| |
Issues in Valuing Pharmacy Services | |
| |
| |
Medicare Medication Therapy Management | |
| |
| |
Summary | |
| |
| |
Composite Article: Pharmacy Services | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
International Perspective | |
| |
| |
Health Care Expenditures | |
| |
| |
Comparability of Pharmacoeconomic Results between Countries | |
| |
| |
History of Pharmacoeconomic Guideline Development | |
| |
| |
Summary | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
| |
Future Issues | |
| |
| |
Application of Pharmacoeconomies in the United Stares | |
| |
| |
Federal Agencies | |
| |
| |
Private Health Care Plans | |
| |
| |
Barriers to Pharmacoeconomies in the United States | |
| |
| |
Other Future Issues | |
| |
| |
Summary | |
| |
| |
Questions/Exercises | |
| |
| |
References | |
| |
| |
Suggested Readings | |
| |
| |
Glossary | |
| |
| |
Index | |